Guy Goldberg

R&D

In episode 31 of the pharmaphorum podcast, Deep Dive editor George Underwood speaks to RedHill biopharma’s chief business officer Guy Goldb

News

For the second time in less than a year, Vinay Prasad has departed from the FDA, after a string of controversial regulatory decisions.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.